fresolimumab (101)							9158

Structure	 

Heavy chain / Chaone lourde / Cadena pesada

QVQLVQSGAE VKKPGSSVKV SCKASGYTFS SNVISWVRQA PGQGLEWMGG  50

VIPIVDIANY AQRFKGRVTI TADESTSTTY MELSSLRSED TAVYYCASTL 100

GLVLDAMDYW GQGTLVTVSS ASTKGPSVFP LAPCSRSTSE STAALGCLVK 150

DYFPEPVTVS WNSGALTSGV HTFPAVLQSS GLYSLSSVVT VPSSSLGTKT 200

YTCNVDHKPS NTKVDKRVES KYGPPCPSCP APEFLGGPSV FLFPPKPKDT 250

LMISRTPEVT CVVVDVSQED PEVQFNWYVD GVEVHNAKTK PREEQFNSTY 300

RVVSVLTVLH QDWLNGKEYK CKVSNKGLPS SIEKTISKAK GQPREPQVYT 350

LPPSQEEMTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS 400

DGSFFLYSRL TVDKSRWQEG NVFSCSVMHE ALHNHYTQKS LSLSLGK    447

Light chain / Chaone lygire / Cadena ligera

ETVLTQSPGT LSLSPGERAT LSCRASQSLG SSYLAWYQQK PGQAPRLLIY  50

GASSRAPGIP DRFSGSGSGT DFTLTISRLE PEDFAVYYCQ QYADSPITFG 100

QGTRLEIKRT VAAPSVFIFP PSDEQLKSGT ASVVCLLNNF YPREAKVQWK 150

VDNALQSGNS QESVTEQDSK DSTYSLSSTL TLSKADYEKH KVYACEVTHQ 200

GLSSPVTKSF NRGEC                                       215

Disulfide bridges location / Position des ponts disulfure / Posiciones
de los puentes disulfuro

Intra-H	22-96	147-203	261-321	367-425

	22??-96??	147??-203??	261??-321??	367??-425??

Intra-L	23?-89?	135?-195?



	23???-89???	135???-195???



Inter-H-L	134-215?	134??-215???



Inter-H-H	226-226??	229-229??





N-glycosylation sites / Sites de N-glycosylation / Posiciones de
N-glicosilaciun

297, 297??

CAS		948564-73-6

Description

immunoglobulin G4-kappa, anti-[Homo sapiens transforming growth factor
beta (TGFB or TGFbeta or TGF-beta, including TGF-beta-1 or TGFB1,
TGF-beta-2 or TGFB2 or G-TsF and TGF-beta-3 or TGFB3)], Homo sapiens
monoclonal antibody; 

gamma4 heavy chain (1-447) [Homo sapiens VH (IGHV1-69*10 (89.70%)
-(IGHD)-IGHJ3*01) [8.8.13] (1-120) -IGHG4*01 (121-447)],
(134-215?)-disulfide with kappa light chain (1?-215?) [Homo sapiens
V-KAPPA (IGKV3-20*01 (93.80%) -IGKJ5*01) [7.3.9] (1?-108?) -IGKC*01
(109?-215?)]; (226-226??:229-229??)-bisdisulfide dimer 

immunoglobuline G4-kappa, anti-[Homo sapiens facteur de croissance
transformant bkta (TGFB ou TGFbkta ou TGF-bkta, comprenant TGF-bkta1 ou
TGFB1, TGF-bkta2 ou TGFB2 ou G-TsF et TGF-bkta3 ou TGFB3)], Homo sapiens
anticorps monoclonal; 

chaone lourde gamma4 (1-447) [Homo sapiens VH (IGHV1-69*10 (89.70%)
-(IGHD)-IGHJ3*01) [8.8.13] (1-120) -IGHG4*01 (121-447)],
(134-215?)-disulfure avec la chaone lygire kappa (1?-215?) [Homo sapiens
V-KAPPA (IGKV3-20*01 (93.80%) -IGKJ5*01) [7.3.9] (1?-108?) -IGKC*01
(109?-215?)]; dimire (226-226??:229-229??)-bisdisulfure

inmunoglobulina G4-kappa, anti-[factor de crecimiento transformador 
beta de Homo sapiens (TGFB o TGFbeta o TGF-beta, incluye TGF-beta-1 o
TGFB1, TGF-beta-2 o TGFB2 o G-TsF y TGF-beta-3 o TGFB3)], anticuerpo
monoclonal de Homo sapiens; 

cadena pesada gamma4 (1-447) [Homo sapiens VH (IGHV1-69*10 (89.70%)
-(IGHD)-IGHJ3*01) [8.8.13] (1-120) -IGHG4*01 (121-447)],
(134-215?)-disulfuro con la cadena ligera kappa (1?-215?) [Homo sapiens
V-KAPPA (IGKV3-20*01 (93.80%) -IGKJ5*01) [7.3.9] (1?-108?) -IGKC*01
(109?-215?)]; dnmero (226-226??:229-229??)-bisdisulfuro

	

WHO 

International Nonproprietary Names Programme	

15/07/2009

p. 1/1

		

